Healthcare provider profile · identity verified

Kenneth Patrick Edel, MD

Family Practice · GASTONIA, NC · NPI 1194787481

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	543	145
Atorvastatin Calcium	Atorvastatin Calcium	388	112
Rosuvastatin Calcium	Rosuvastatin Calcium	361	103
Levothyroxine Sodium	Levothyroxine Sodium	354	89
Lisinopril	Lisinopril	321	91
Gabapentin	Gabapentin	248	57
Omeprazole	Omeprazole	200	55
Losartan Potassium	Losartan Potassium	195	55
Hydrochlorothiazide	Hydrochlorothiazide	194	55
Metformin Hcl Er	Metformin Hcl	194	53
Ozempic	Semaglutide	178	34
Metoprolol Succinate	Metoprolol Succinate	168	46
Pantoprazole Sodium	Pantoprazole Sodium	131	35
Tamsulosin Hcl	Tamsulosin Hcl	122	27
Carvedilol	Carvedilol	116	31
Montelukast Sodium	Montelukast Sodium	114	28
Spironolactone	Spironolactone	106	29
Escitalopram Oxalate	Escitalopram Oxalate	105	25
Potassium Chloride	Potassium Chloride	101	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	94	24
Valsartan	Valsartan	94	26
Alendronate Sodium	Alendronate Sodium	93	19
Buspirone Hcl	Buspirone Hcl	93	20
Pravastatin Sodium	Pravastatin Sodium	93	24
Allopurinol	Allopurinol	80	22
Fluticasone Propionate	Fluticasone Propionate	76	28
Furosemide	Furosemide	76	21
Fluoxetine Hcl	Fluoxetine Hcl	74	19
Famotidine	Famotidine	71	17
Simvastatin	Simvastatin	67	20
Albuterol Sulfate Hfa	Albuterol Sulfate	64	26
Meloxicam	Meloxicam	63	22
Sertraline Hcl	Sertraline Hcl	63	18
Metformin Hcl	Metformin Hcl	62	18
Jardiance	Empagliflozin	59	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	58	15
Cephalexin	Cephalexin	57	35
Clopidogrel	Clopidogrel Bisulfate	54	16
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	53	14
Farxiga	Dapagliflozin Propanediol	52	suppressed
Ezetimibe	Ezetimibe	50	suppressed
Prednisone	Prednisone	47	35
Synthroid	Levothyroxine Sodium	46	suppressed
Benazepril Hcl	Benazepril Hcl	45	12
Esomeprazole Magnesium	Esomeprazole Magnesium	44	11
Telmisartan	Telmisartan	44	11
Metoprolol Tartrate	Metoprolol Tartrate	43	14
Bisoprolol Fumarate	Bisoprolol Fumarate	42	suppressed
Tramadol Hcl	Tramadol Hcl	42	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	36	suppressed
Ipratropium Bromide	Ipratropium Bromide	35	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	12
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Mupirocin	Mupirocin	32	21
Warfarin Sodium	Warfarin Sodium	32	suppressed
Ramipril	Ramipril	31	suppressed
Valacyclovir	Valacyclovir Hcl	29	12
Atenolol	Atenolol	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Mounjaro	Tirzepatide	28	suppressed
Chlorthalidone	Chlorthalidone	27	suppressed
Eliquis	Apixaban	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Colchicine	Colchicine	24	11
Finasteride	Finasteride	23	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Amoxicillin	Amoxicillin	21	19
Bupropion Xl	Bupropion Hcl	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	15
Azithromycin	Azithromycin	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Torsemide	Torsemide	20	suppressed
Estradiol	Estradiol	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	13
Trulicity	Dulaglutide	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	13
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Diazepam	Diazepam	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Lamotrigine	Lamotrigine	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Trazodone Hcl	Trazodone Hcl	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Minoxidil	Minoxidil	15	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	14	suppressed
Eplerenone	Eplerenone	14	suppressed
Risperidone	Risperidone	14	suppressed
Cefdinir	Cefdinir	13	13
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error